Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CAR T Cell Therapy
1.2.3 TCR Therapy
1.2.4 TIL Therapy
1.3 Market by Application
1.3.1 Global T-Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global T-Cell Therapy Market Perspective (2016-2027)
2.2 T-Cell Therapy Growth Trends by Regions
2.2.1 T-Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T-Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 T-Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 T-Cell Therapy Industry Dynamic
2.3.1 T-Cell Therapy Market Trends
2.3.2 T-Cell Therapy Market Drivers
2.3.3 T-Cell Therapy Market Challenges
2.3.4 T-Cell Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top T-Cell Therapy Players by Revenue
3.1.1 Global Top T-Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T-Cell Therapy Revenue
3.4 Global T-Cell Therapy Market Concentration Ratio
3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2020
3.5 T-Cell Therapy Key Players Head office and Area Served
3.6 Key Players T-Cell Therapy Product Solution and Service
3.7 Date of Enter into T-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Therapy Breakdown Data by Type
4.1 Global T-Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global T-Cell Therapy Forecasted Market Size by Type (2022-2027)

5 T-Cell Therapy Breakdown Data by Application
5.1 Global T-Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global T-Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America T-Cell Therapy Market Size (2016-2027)
6.2 North America T-Cell Therapy Market Size by Type
6.2.1 North America T-Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America T-Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America T-Cell Therapy Market Size by Type (2016-2027)
6.3 North America T-Cell Therapy Market Size by Application
6.3.1 North America T-Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America T-Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America T-Cell Therapy Market Size by Application (2016-2027)
6.4 North America T-Cell Therapy Market Size by Country
6.4.1 North America T-Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America T-Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe T-Cell Therapy Market Size (2016-2027)
7.2 Europe T-Cell Therapy Market Size by Type
7.2.1 Europe T-Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe T-Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe T-Cell Therapy Market Size by Type (2016-2027)
7.3 Europe T-Cell Therapy Market Size by Application
7.3.1 Europe T-Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe T-Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe T-Cell Therapy Market Size by Application (2016-2027)
7.4 Europe T-Cell Therapy Market Size by Country
7.4.1 Europe T-Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe T-Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific T-Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific T-Cell Therapy Market Size by Type
8.2.1 Asia-Pacific T-Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific T-Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific T-Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific T-Cell Therapy Market Size by Application
8.3.1 Asia-Pacific T-Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T-Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T-Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific T-Cell Therapy Market Size by Region
8.4.1 Asia-Pacific T-Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T-Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America T-Cell Therapy Market Size (2016-2027)
9.2 Latin America T-Cell Therapy Market Size by Type
9.2.1 Latin America T-Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America T-Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America T-Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America T-Cell Therapy Market Size by Application
9.3.1 Latin America T-Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America T-Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America T-Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America T-Cell Therapy Market Size by Country
9.4.1 Latin America T-Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America T-Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa T-Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa T-Cell Therapy Market Size by Type
10.2.1 Middle East & Africa T-Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa T-Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa T-Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa T-Cell Therapy Market Size by Application
10.3.1 Middle East & Africa T-Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T-Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T-Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa T-Cell Therapy Market Size by Country
10.4.1 Middle East & Africa T-Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T-Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Details
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. T-Cell Therapy Introduction
11.1.4 Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 Sorrento Therapeutics
11.2.1 Sorrento Therapeutics Company Details
11.2.2 Sorrento Therapeutics Business Overview
11.2.3 Sorrento Therapeutics T-Cell Therapy Introduction
11.2.4 Sorrento Therapeutics Revenue in T-Cell Therapy Business (2016-2021)
11.2.5 Sorrento Therapeutics Recent Development
11.3 Fate Therapeutics Inc.
11.3.1 Fate Therapeutics Inc. Company Details
11.3.2 Fate Therapeutics Inc. Business Overview
11.3.3 Fate Therapeutics Inc. T-Cell Therapy Introduction
11.3.4 Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.3.5 Fate Therapeutics Inc. Recent Development
11.4 Novartis International AG
11.4.1 Novartis International AG Company Details
11.4.2 Novartis International AG Business Overview
11.4.3 Novartis International AG T-Cell Therapy Introduction
11.4.4 Novartis International AG Revenue in T-Cell Therapy Business (2016-2021)
11.4.5 Novartis International AG Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Details
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. T-Cell Therapy Introduction
11.5.4 AbbVie Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.5.5 AbbVie Inc. Recent Development
11.6 Adaptimmune Therapeutics PLC
11.6.1 Adaptimmune Therapeutics PLC Company Details
11.6.2 Adaptimmune Therapeutics PLC Business Overview
11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Introduction
11.6.4 Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2016-2021)
11.6.5 Adaptimmune Therapeutics PLC Recent Development
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Details
11.7.2 Bluebird Bio Business Overview
11.7.3 Bluebird Bio T-Cell Therapy Introduction
11.7.4 Bluebird Bio Revenue in T-Cell Therapy Business (2016-2021)
11.7.5 Bluebird Bio Recent Development
11.8 TCR2 Therapeutics, Inc.
11.8.1 TCR2 Therapeutics, Inc. Company Details
11.8.2 TCR2 Therapeutics, Inc. Business Overview
11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Introduction
11.8.4 TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.8.5 TCR2 Therapeutics, Inc. Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. T-Cell Therapy Introduction
11.9.4 Pfizer Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.9.5 Pfizer Inc. Recent Development
11.10 DiaCarta, Inc.
11.10.1 DiaCarta, Inc. Company Details
11.10.2 DiaCarta, Inc. Business Overview
11.10.3 DiaCarta, Inc. T-Cell Therapy Introduction
11.10.4 DiaCarta, Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.10.5 DiaCarta, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global T-Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CAR T Cell Therapy
Table 3. Key Players of TCR Therapy
Table 4. Key Players of TIL Therapy
Table 5. Global T-Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global T-Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global T-Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global T-Cell Therapy Market Share by Regions (2016-2021)
Table 9. Global T-Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global T-Cell Therapy Market Share by Regions (2022-2027)
Table 11. T-Cell Therapy Market Trends
Table 12. T-Cell Therapy Market Drivers
Table 13. T-Cell Therapy Market Challenges
Table 14. T-Cell Therapy Market Restraints
Table 15. Global T-Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global T-Cell Therapy Market Share by Players (2016-2021)
Table 17. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Therapy as of 2020)
Table 18. Ranking of Global Top T-Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by T-Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players T-Cell Therapy Product Solution and Service
Table 22. Date of Enter into T-Cell Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global T-Cell Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global T-Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global T-Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global T-Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global T-Cell Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global T-Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global T-Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America T-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America T-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe T-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe T-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific T-Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific T-Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America T-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America T-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa T-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa T-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Gilead Sciences, Inc. Company Details
Table 63. Gilead Sciences, Inc. Business Overview
Table 64. Gilead Sciences, Inc. T-Cell Therapy Product
Table 65. Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 66. Gilead Sciences, Inc. Recent Development
Table 67. Sorrento Therapeutics Company Details
Table 68. Sorrento Therapeutics Business Overview
Table 69. Sorrento Therapeutics T-Cell Therapy Product
Table 70. Sorrento Therapeutics Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 71. Sorrento Therapeutics Recent Development
Table 72. Fate Therapeutics Inc. Company Details
Table 73. Fate Therapeutics Inc. Business Overview
Table 74. Fate Therapeutics Inc. T-Cell Therapy Product
Table 75. Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 76. Fate Therapeutics Inc. Recent Development
Table 77. Novartis International AG Company Details
Table 78. Novartis International AG Business Overview
Table 79. Novartis International AG T-Cell Therapy Product
Table 80. Novartis International AG Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 81. Novartis International AG Recent Development
Table 82. AbbVie Inc. Company Details
Table 83. AbbVie Inc. Business Overview
Table 84. AbbVie Inc. T-Cell Therapy Product
Table 85. AbbVie Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 86. AbbVie Inc. Recent Development
Table 87. Adaptimmune Therapeutics PLC Company Details
Table 88. Adaptimmune Therapeutics PLC Business Overview
Table 89. Adaptimmune Therapeutics PLC T-Cell Therapy Product
Table 90. Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 91. Adaptimmune Therapeutics PLC Recent Development
Table 92. Bluebird Bio Company Details
Table 93. Bluebird Bio Business Overview
Table 94. Bluebird Bio T-Cell Therapy Product
Table 95. Bluebird Bio Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 96. Bluebird Bio Recent Development
Table 97. TCR2 Therapeutics, Inc. Company Details
Table 98. TCR2 Therapeutics, Inc. Business Overview
Table 99. TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 100. TCR2 Therapeutics, Inc. Recent Development
Table 101. Pfizer Inc. Company Details
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. T-Cell Therapy Product
Table 104. Pfizer Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 105. Pfizer Inc. Recent Development
Table 106. DiaCarta, Inc. Company Details
Table 107. DiaCarta, Inc. Business Overview
Table 108. DiaCarta, Inc. T-Cell Therapy Product
Table 109. DiaCarta, Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 110. DiaCarta, Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. CAR T Cell Therapy Features
Figure 3. TCR Therapy Features
Figure 4. TIL Therapy Features
Figure 5. Global T-Cell Therapy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics & Ambulatory Centers Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. T-Cell Therapy Report Years Considered
Figure 11. Global T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global T-Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global T-Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global T-Cell Therapy Market Share by Regions (2022-2027)
Figure 15. Global T-Cell Therapy Market Share by Players in 2020
Figure 16. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by T-Cell Therapy Revenue in 2020
Figure 18. Global T-Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global T-Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America T-Cell Therapy Market Share by Type (2016-2027)
Figure 22. North America T-Cell Therapy Market Share by Application (2016-2027)
Figure 23. North America T-Cell Therapy Market Share by Country (2016-2027)
Figure 24. United States T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe T-Cell Therapy Market Share by Type (2016-2027)
Figure 28. Europe T-Cell Therapy Market Share by Application (2016-2027)
Figure 29. Europe T-Cell Therapy Market Share by Country (2016-2027)
Figure 30. Germany T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific T-Cell Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific T-Cell Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific T-Cell Therapy Market Share by Region (2016-2027)
Figure 40. China T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America T-Cell Therapy Market Share by Type (2016-2027)
Figure 48. Latin America T-Cell Therapy Market Share by Application (2016-2027)
Figure 49. Latin America T-Cell Therapy Market Share by Country (2016-2027)
Figure 50. Mexico T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa T-Cell Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa T-Cell Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa T-Cell Therapy Market Share by Country (2016-2027)
Figure 56. Turkey T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Gilead Sciences, Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 60. Sorrento Therapeutics Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 61. Fate Therapeutics Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 62. Novartis International AG Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 63. AbbVie Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 64. Adaptimmune Therapeutics PLC Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 65. Bluebird Bio Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 66. TCR2 Therapeutics, Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 67. Pfizer Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 68. DiaCarta, Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed